Detalles de la búsqueda
1.
Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
Int J Cancer;
150(4): 626-635, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558665
2.
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
BMC Cancer;
21(1): 859, 2021 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34315431
3.
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.
BMC Cancer;
21(1): 309, 2021 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33761908
4.
Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary disease.
BMC Pulm Med;
21(1): 22, 2021 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33435937
5.
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED.
Am J Respir Crit Care Med;
195(4): 443-455, 2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27580351
6.
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
Eur Respir J;
49(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28179442
7.
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective study.
Aging (Albany NY);
16(1): 550-567, 2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194721
8.
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Ther Adv Med Oncol;
16: 17588359231222604, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249338
9.
DNA methylation modules in airway smooth muscle are associated with asthma severity.
Eur Respir J;
51(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449426
10.
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer.
Thorac Cancer;
14(4): 348-356, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525509
11.
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.
Thorac Cancer;
14(25): 2548-2557, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37525557
12.
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan.
Thorac Cancer;
14(1): 12-23, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36424878
13.
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study).
Am J Cancer Res;
13(7): 3100-3112, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37559987
14.
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer.
Am J Cancer Res;
13(9): 4208-4221, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818047
15.
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.
Sci Rep;
13(1): 20323, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989860
16.
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma.
Cancers (Basel);
14(3)2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158940
17.
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients.
Thorac Cancer;
13(13): 1888-1897, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35633141
18.
Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.
Cancers (Basel);
14(14)2022 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884531
19.
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.
Cancers (Basel);
14(4)2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205720
20.
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations.
Anticancer Res;
42(4): 2145-2157, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347039